Your browser does not support JavaScript capabilities, which maybe required to display this page properly.


PDF FormatRequires Adobe Acrobat Reader

Table 9.6c

Immunosuppression Use for Induction by Steroid Use at Discharge, 2004 to 2008

Recipients with Liver Transplants

  No Steroids Used for Maintenance Steroids Used for Maintenance
N % N %
Functioning Graft with Immunosuppression Info at Discharge 6,209 100.0% 23,030 100.0%
Induction Drugs        
Atgam/NRATG/NRATS 147 2.4% 41 0.2%
OKT3 20 0.3% 60 0.3%
Thymoglobulin 1,482 23.9% 1,016 4.4%
Zenapax 625 10.1% 1,139 4.9%
Simulect 636 10.2% 1,234 5.4%
Campath 270 4.3% 140 0.6%
Rituximab 419 6.7% 27 0.1%
No Induction Drug Reported 3,082 49.6% 19,468 84.5%


Source: OPTN/SRTR Data as of May 4, 2009.

Includes patients with a functioning graft at discharge.

Steroids used for induction are not counted.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.



PDF FormatRequires Adobe Acrobat Reader